AU2002225914A1 - Plasmid vectors - Google Patents

Plasmid vectors

Info

Publication number
AU2002225914A1
AU2002225914A1 AU2002225914A AU2591402A AU2002225914A1 AU 2002225914 A1 AU2002225914 A1 AU 2002225914A1 AU 2002225914 A AU2002225914 A AU 2002225914A AU 2591402 A AU2591402 A AU 2591402A AU 2002225914 A1 AU2002225914 A1 AU 2002225914A1
Authority
AU
Australia
Prior art keywords
plasmid vectors
plasmid
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002225914A
Inventor
Shana Barbas-Frederickson
Katherine S. Bowdish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alexion Pharmaceuticals Inc
Original Assignee
Alexion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharmaceuticals Inc filed Critical Alexion Pharmaceuticals Inc
Publication of AU2002225914A1 publication Critical patent/AU2002225914A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
AU2002225914A 2000-12-08 2001-12-07 Plasmid vectors Abandoned AU2002225914A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25441000P 2000-12-08 2000-12-08
US60/254,410 2000-12-08
PCT/US2001/046514 WO2002046434A2 (en) 2000-12-08 2001-12-07 Plasmid vectors

Publications (1)

Publication Number Publication Date
AU2002225914A1 true AU2002225914A1 (en) 2002-06-18

Family

ID=22964206

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002225914A Abandoned AU2002225914A1 (en) 2000-12-08 2001-12-07 Plasmid vectors

Country Status (3)

Country Link
US (1) US20050191749A1 (en)
AU (1) AU2002225914A1 (en)
WO (1) WO2002046434A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008067547A2 (en) 2006-11-30 2008-06-05 Research Development Foundation Improved immunoglobulin libraries

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU662148B2 (en) * 1991-04-10 1995-08-24 Scripps Research Institute, The Heterodimeric receptor libraries using phagemids
DE69333969T2 (en) * 1992-10-30 2006-09-14 The General Hospital Corp., Boston Interactive trap system for the isolation of proteins
US5589362A (en) * 1993-06-14 1996-12-31 Basf Aktiengesellschaft Tetracycline regulated transcriptional modulators with altered DNA binding specificities
EP0724651B1 (en) * 1993-10-19 2008-08-20 The Scripps Research Institute Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus
AU6163196A (en) * 1995-06-07 1996-12-30 Smithkline Beecham Corporation Method for obtaining receptor agonist antibodies
ES2199431T3 (en) * 1997-01-31 2004-02-16 Cosmix Molecular Biologicals Gmbh GENERATION OF DIVERSITY IN COMBINATORY GENOTECAS.
US6190908B1 (en) * 1998-08-12 2001-02-20 The Scripps Research Institute Modulation of polypeptide display on modified filamentous phage
US7396917B2 (en) * 2000-12-05 2008-07-08 Alexion Pharmaceuticals, Inc. Rationally designed antibodies

Also Published As

Publication number Publication date
WO2002046434A3 (en) 2004-03-25
US20050191749A1 (en) 2005-09-01
WO2002046434A2 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
AU2001262847A1 (en) Language-understanding
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
AU2001232054A1 (en) Vector
AU2001245494A1 (en) Flexible laminations
AU2001258924A1 (en) Microsatellite-aflp
AU2001240791A1 (en) Sequence
AU2001242625A1 (en) Gene sequence
AU2001240103A1 (en) Reproduction-specific genes
AU2001246864A1 (en) Hypotensors
AU2001288839A1 (en) Self-rearranging dna vectors
AU4672401A (en) Vectors
AU2001260192A1 (en) Glycinamides
AU2001262711A1 (en) Cytoprotectors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2002225914A1 (en) Plasmid vectors
AU2001275014A1 (en) Imidazoloisoquinolines
AU2001251324A1 (en) An endogenous ketogulonigenium plasmid
AU2002218022A1 (en) Plasmid vectors
AU2002211324A1 (en) Oxidoreductases
AU2001212995A1 (en) Improved spectacles
AU2001256287A1 (en) 2-phenyl-2h-pyridazine-3-ones